To include your compound in the COVID-19 Resource Center, submit it here.

Custirsen sodium: Completed Phase III enrollment

OncoGenex completed enrollment in the open-label, international Phase III AFFINITY trial comparing IV custirsen plus Jevtana cabazitaxel and prednisone vs.

Read the full 208 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE